
结论很明确:这个市场不适合现在进入。 目前只看到 1 个可验证的新品牌成功样本,且成功几乎完全被 SKIN1004 这一家拿走;这不是一个适合小商家低成本切入的赛道,更像是需要功能创新和品牌投放能力的大品牌战场。
从数据看,市场没有出现你担心的“30~100+ 新品牌涌入”的典型超饱和信号,但也绝不是健康机会。当前新品牌总数只有 1 个,成功率表面上是 100%,可样本只有 1 条,不能当成高机会证据;这条成功样本是 SKIN1004 的 B0FDXXJT66,售价 12.35 美元,月销 700 件,月营收 864,500 美元,利润率 20.41%,早期投入约 12,038 美元,广告就占约 2,699 美元。它能跑出来的核心不是低价,而是BRAND_POWER + DIFFERENTIATE_FUNCTION_FEATURE,具体是 10% 烟酰胺、传明酸、积雪草,再加 spicule 微针质地,这种打法对新手并不友好。按利润结构看,当前可见的新产品利润区间集中在 20%+,说明不是价格战最惨烈的那一档,但也已经进入“需要明显差异化才能赢”的阶段,不是简单复制就能做的市场。
对两类玩家来说,结论都偏负面。对大品牌,虽然预算上你有 500,000 CNY,单个 ASIN 的启动资金表面够用,但这只覆盖前期打样、发货和投放,后面还要算研发、品牌和认证;在这个市场里,真正能参考的只有 SKIN1004 这种强势新品牌案例,属于“有资源、有功能突破才可能进”。对小商家,没有合格的真实小商家成功样本,因为唯一的成功者评论数已经到 933,远高于 300 的小商家门槛,不能当作小商家案例;这意味着如果你要进场,基本只能走高投入、强内容、强功能差异路线,否则很难打赢。市场趋势也没有给出扩张证据,近几年几乎空白,直到 2025 年才出现这一条成功记录,说明当前不是一个已经被很多品牌证明可复制的机会。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
结论很直接:你现在的50万人民币预算足够切入这条线,但这条市场并不适合“低预算试水”——要想做成,必须用接近中高配的新品预算,并且不能把老品牌当成小商家案例。 目前能看到的强势新品是 SKIN1004 的 B0FDXXJT66:定价约$12.35,月销约700件,月收入约864,500美元,利润率20.41%,说明不是靠低价硬拼,而是靠品牌力和功能差异一起拉动。
Alternative solutions may pose a risk to your investment in certain markets.
这个市场不建议进入:当前样本里只有 1 个可确认的盈利新上市,且来自 SKIN1004,说明结果被单一大品牌主导,不是适合新手或小品牌切入的环境。虽然这个样本 ASIN 看起来有 20.4% 利润率、700 件/月销量、约 8,645 美元/月收入,但它靠的是品牌力+功能差异化,不是低成本可复制模型。
证据很直接:SKIN1004 的 B0FDXXJT66,售价 12.35 美元,月销 700 件,最新评分 4.4,评论 933,早期投入约 12,038 美元,其中广告约 2,699 美元;利润率 20.4%,近月利润约 1,764 美元。它的核心卖点是“10% 烟酰胺 + 传明酸 + 积雪草 + spicule 微针质地”,属于明确的功能差异化,不是普通同质化产品。市场趋势上,按年份和月份看,近几年可识别的新上市几乎都没有展开,2025 年只出现这一条成功记录,说明当前可验证的增长并不充分;同时,这个成功产品的评论已经到 933,远高于“<300 评论”的真实小商家样本门槛,应视为偏强势竞争者,而不是小商家可直接对标的案例。
可参考的只有一个“强势大品牌成功案例”:SKIN1004 / B0FDXXJT66,应该复制的是功能组合、功效定位和韩系高端感,不是它的品牌影响力。对小商家来说,没有合格的真实小商家成功样本;这意味着如果你要进场,至少要准备同级别的产品研发、内容教育和投放能力,否则很容易被大品牌的功能型新品直接压制。结论很硬:大品牌有机会,小商家没有清晰可行的低成本路径,这个市场不适合现在进入。
这个市场不适合进入:当前只有1个新品牌样本,而且唯一可见的成功案例是 SKIN1004 的 B0FDXXJT66,利润率20.4%、月销700、月营收$8,645、近月利润$1,764.45,属于“能卖、但靠品牌力和功能差异撑起来”的案例,不是普通小商家可以直接复制的低门槛机会。 现在看不到30~100+新品牌涌入的超饱和信号,但样本极少,不能把它解读成好市场;相反,成功高度集中在单一品牌,且这个品牌还是新入场后快速跑出来的强势案例,说明要么需要明显的产品创新,要么需要较重的品牌与推广投入。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
B0FDXXJT66 | SKIN1004 | 2025-08-13 | Yes | $12.35 | 700pcs | $8645.0 | 20.41% | $1764.45 |
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
B0FDXXJT66 | SKIN1004 | 2025-08-13 | Yes | $12.35 | 700pcs | $8645.0 | 20.41% | $1764.45 |
这个市场不适合现在进入,核心问题不是“有没有机会”,而是已经被头部品牌和高投入打法锁死了。 目前可见的成功样本几乎全部来自 SKIN1004,且这类新上架产品要做到 20.4% 的利润率,早期总投入已经到 12,038.29 美元,其中广告就占 2,698.98 美元;对用户 500,000 CNY 的预算来说,单个 SKU 的启动资金表面上够,但这只是前期成本,后续品牌建设、创新和认证成本还没算进去。
What is the ratio of profitable products
What is the ratio of different brands owning all profitable new products
这不是一个适合进入的市场。 目前只有 1 个新品牌、1 个新上架产品,样本极小,无法证明市场有稳定机会;但这唯一的成功样本就已经需要 20.4% 的利润率和约 12,038.29 美元的早期投入,说明门槛不低,且更像是靠品牌力和投放推动,不是低成本小卖家能轻松复制的赛道。
从数据看,市场还没有出现你担心的那种“30~100+ 新品牌涌入”的典型过热信号,但也绝不是好进的市场:近几年新上架几乎空白,直到 2025 年才出现 1 个新品牌 SKIN1004 和 1 个新产品 B0FDXXJT66,而且该产品 700 月销量、933 评论、4.4 分、20.4% 利润率、首 3 个月平均 400 单,属于强势样本。问题在于,成功并没有扩散到更多新品牌,说明不是“新品牌普遍能做成”,而是少数案例跑出来;再加上这条样本的早期投入不低,用户预算 500,000 CNY 虽然覆盖得起单个 ASIN 的启动,但这不代表能复制出长期竞争力,尤其如果后续还要做研发、品牌和认证,成本会继续上升。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| 2026 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/8 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| 2025/9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |